OCA
KLRS
Octagon Capital Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $961K | Sell |
360,000
-121,000
| -25% | -$323K | 0.21% | 28 |
|
|
2025
Q1 | $3.86M | Sell |
481,000
-10,734,000
| -96% | -$86.2M | 0.75% | 32 |
|
|
2024
Q4 | $4.71M | Buy |
11,215,000
+13,000
| +0.1% | +$5.46K | 0.78% | 27 |
|
|
2024
Q3 | $9.06M | Buy |
11,202,000
+1,402,000
| +14% | +$1.13M | 1.41% | 20 |
|
|
2024
Q2 | $7.09M | Buy |
9,800,000
+5,600,000
| +133% | +$4.05M | 1.11% | 22 |
|
|
2024
Q1 | $3.17M | Buy |
+4,200,000
| New | +$3.17M | 0.38% | 46 |
|